Chemotherapy for extraocular retinoblastoma

Charles B. Pratt, James Fontanesi, Peter Chenaille, Larry E. Kun, Jesse J. Jenkins, James W. Langston, Kevin G. Mounce, David Meyer

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Because few patients with extraocular retinoblastoma are seen in the United Skates and Europe, it has been difficult to establish the optimal role of chemotherapy in such cases. We examined the efficacy of two chemotherapy combinations (cisplatinletoposide and cyclophospha-mide/doxorubicin) in patients with extraretinal retinoblastoma, administered prior to radiotherapy in four patients with recurrent or advanced prinav disease. Responses were evaluable in three patients, each of whom was treated by both chemotherapy regimeas and radiotherapy. Multimodality therapy promises to be of benefit to patients with extraocular retinoblastoma, and future studies will explore alternative chemotherapy combinations for this purpose.

Original languageEnglish (US)
Pages (from-to)301-309
Number of pages9
JournalPediatric Hematology and Oncology
Volume11
Issue number3
DOIs
StatePublished - Jan 1 1994

Fingerprint

Retinoblastoma
Drug Therapy
Combination Drug Therapy
Radiotherapy
Doxorubicin

Keywords

  • Chemotherapy
  • Metastases
  • Radiation therapy
  • Retinoblastoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Pratt, C. B., Fontanesi, J., Chenaille, P., Kun, L. E., Jenkins, J. J., Langston, J. W., ... Meyer, D. (1994). Chemotherapy for extraocular retinoblastoma. Pediatric Hematology and Oncology, 11(3), 301-309. https://doi.org/10.3109/08880019409141673

Chemotherapy for extraocular retinoblastoma. / Pratt, Charles B.; Fontanesi, James; Chenaille, Peter; Kun, Larry E.; Jenkins, Jesse J.; Langston, James W.; Mounce, Kevin G.; Meyer, David.

In: Pediatric Hematology and Oncology, Vol. 11, No. 3, 01.01.1994, p. 301-309.

Research output: Contribution to journalArticle

Pratt, CB, Fontanesi, J, Chenaille, P, Kun, LE, Jenkins, JJ, Langston, JW, Mounce, KG & Meyer, D 1994, 'Chemotherapy for extraocular retinoblastoma', Pediatric Hematology and Oncology, vol. 11, no. 3, pp. 301-309. https://doi.org/10.3109/08880019409141673
Pratt CB, Fontanesi J, Chenaille P, Kun LE, Jenkins JJ, Langston JW et al. Chemotherapy for extraocular retinoblastoma. Pediatric Hematology and Oncology. 1994 Jan 1;11(3):301-309. https://doi.org/10.3109/08880019409141673
Pratt, Charles B. ; Fontanesi, James ; Chenaille, Peter ; Kun, Larry E. ; Jenkins, Jesse J. ; Langston, James W. ; Mounce, Kevin G. ; Meyer, David. / Chemotherapy for extraocular retinoblastoma. In: Pediatric Hematology and Oncology. 1994 ; Vol. 11, No. 3. pp. 301-309.
@article{b05f7b14e2704c788ac1b11dd5f7d6d6,
title = "Chemotherapy for extraocular retinoblastoma",
abstract = "Because few patients with extraocular retinoblastoma are seen in the United Skates and Europe, it has been difficult to establish the optimal role of chemotherapy in such cases. We examined the efficacy of two chemotherapy combinations (cisplatinletoposide and cyclophospha-mide/doxorubicin) in patients with extraretinal retinoblastoma, administered prior to radiotherapy in four patients with recurrent or advanced prinav disease. Responses were evaluable in three patients, each of whom was treated by both chemotherapy regimeas and radiotherapy. Multimodality therapy promises to be of benefit to patients with extraocular retinoblastoma, and future studies will explore alternative chemotherapy combinations for this purpose.",
keywords = "Chemotherapy, Metastases, Radiation therapy, Retinoblastoma",
author = "Pratt, {Charles B.} and James Fontanesi and Peter Chenaille and Kun, {Larry E.} and Jenkins, {Jesse J.} and Langston, {James W.} and Mounce, {Kevin G.} and David Meyer",
year = "1994",
month = "1",
day = "1",
doi = "10.3109/08880019409141673",
language = "English (US)",
volume = "11",
pages = "301--309",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Chemotherapy for extraocular retinoblastoma

AU - Pratt, Charles B.

AU - Fontanesi, James

AU - Chenaille, Peter

AU - Kun, Larry E.

AU - Jenkins, Jesse J.

AU - Langston, James W.

AU - Mounce, Kevin G.

AU - Meyer, David

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Because few patients with extraocular retinoblastoma are seen in the United Skates and Europe, it has been difficult to establish the optimal role of chemotherapy in such cases. We examined the efficacy of two chemotherapy combinations (cisplatinletoposide and cyclophospha-mide/doxorubicin) in patients with extraretinal retinoblastoma, administered prior to radiotherapy in four patients with recurrent or advanced prinav disease. Responses were evaluable in three patients, each of whom was treated by both chemotherapy regimeas and radiotherapy. Multimodality therapy promises to be of benefit to patients with extraocular retinoblastoma, and future studies will explore alternative chemotherapy combinations for this purpose.

AB - Because few patients with extraocular retinoblastoma are seen in the United Skates and Europe, it has been difficult to establish the optimal role of chemotherapy in such cases. We examined the efficacy of two chemotherapy combinations (cisplatinletoposide and cyclophospha-mide/doxorubicin) in patients with extraretinal retinoblastoma, administered prior to radiotherapy in four patients with recurrent or advanced prinav disease. Responses were evaluable in three patients, each of whom was treated by both chemotherapy regimeas and radiotherapy. Multimodality therapy promises to be of benefit to patients with extraocular retinoblastoma, and future studies will explore alternative chemotherapy combinations for this purpose.

KW - Chemotherapy

KW - Metastases

KW - Radiation therapy

KW - Retinoblastoma

UR - http://www.scopus.com/inward/record.url?scp=0028287847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028287847&partnerID=8YFLogxK

U2 - 10.3109/08880019409141673

DO - 10.3109/08880019409141673

M3 - Article

C2 - 8060814

AN - SCOPUS:0028287847

VL - 11

SP - 301

EP - 309

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 3

ER -